Correction, Sept. 9: The list price of Zepbound has been revised from an earlier version of this article. Eli Lilly’s decision to sell its obesity drug Zepbound directly to patients for $499 per month ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. In industries where consumers take control, transformation ...
It turns out there’s a hack for that. Businesses that want to sell to other businesses can circumvent the usual process of offering their products and services directly to potential business customers ...
The United States healthcare system is failing. We rank last among developed countries in healthcare performance, and Americans face lower life expectancy and growing chronic disease rates despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback